Table 3.
Treatment results as assessed by ophthalmologic examination in the group of patients treated previously with intravenous steroids (n = 101)—the left eye
| NOSPECT | The left eye before steroid treatment | The left eye after steroid treatment | p (Mc Nemara) | |
|---|---|---|---|---|
| Soft tissues | Normal | 14/101 (13.8%) | 16/42 (38.1%) | 0.0014 |
| Grade 3 | 1/101 (1.0%) | 0/42 (0.0%) | 0.5165 | |
| Grade 2 | 32/101 (31.7%) | 0/42 (0.0%) | ||
| Grade 1 | 54/101 (53.5%) | 26/42 (61.9%) | ||
| Not examined | 0/101 (0.0%) | 59/101 (58.4%) | ||
| Exophthalmos | Normal | 54/101 (53.5%) | 23/42 (54.8%) | 0.8873 |
| Grade 3 | 4/101 (3.9%) | 0/42 (0.0%) | 0.1965 | |
| Grade 2 | 12/101 (11.9%) | 6/42 (14.3%) | ||
| Grade 1 | 31/101 (30.7%) | 13/42 (30.9%) | ||
| Not examined | 0/101 (0.0%) | 59/101 (58.4%) | ||
| Oculomotor muscles | Normal | 15/101 (14.9%) | 9/42 (21.4%) | |
| Grade 3 | 5/101 (4.9%) | 0/42 (0.0%) | 0.3454 | |
| Grade 2 | 37/101 (36.6%) | 12/42 (28.6%) | 0.1465 | |
| Grade 1 | 44/101 (43.6%) | 21/42 (50.0%) | ||
| Not examined | 0/101 (0.0%) | 59/101 (58.4%) | ||
| Cornea | Normal | 88/101 (87.1%) | 33/42 (78.6%) | 0.2017 |
| Grade 3 | 1/101 (1.0%) | 0/42 (0.0%) | 0.5165 | |
| Grade 2 | 1/101 (1.0%) | 0/42 (0.0%) | ||
| Grade 1 | 11/101 (10.9%) | 9/42 (21.4%) | ||
| Not examined | 0/101 (0.0%) | 59/101 (58.4%) | ||
| Visual acuity | Normal | 6/101 (5.9%) | 0/42 (0.0%) | 0.1101 |
| Grade 3 | 2/101 (2.0%) | 0/42 (0.0%) | 0.3576 | |
| Grade 2 | 0/101 (0.0%) | 0/42 (0.0%) | ||
| Grade 1 | 93/101 (92.1%) | 42/42 (100.0%) | ||
| Not examined | 0/101 (0.0%) | 59/101 (58.4%) |